{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Adipose+Derived+Mesenchymal+Stem+Cells", "query": { "intervention": "Adipose Derived Mesenchymal Stem Cells" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 69, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Adipose+Derived+Mesenchymal+Stem+Cells&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-02T07:33:15.075Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04744051", "title": "ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Post-Concussion Syndrome" ], "interventions": [ { "name": "50 Adipose Derived Stem Cell Infusion", "type": "DRUG" }, { "name": "150 Adipose Derived Stem Cell Infusion", "type": "DRUG" }, { "name": "300 Adipose Derived Stem Cell Infusion", "type": "DRUG" }, { "name": "Placebo Infusion", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "American CryoStem Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2021-02-01", "completion_date": "2024-01-31", "has_results": false, "last_update_posted_date": "2023-06-09", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 1, "location_summary": "La Mesa, California", "locations": [ { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04744051" }, { "nct_id": "NCT02068794", "title": "MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Fallopian Tube Clear Cell Adenocarcinoma", "Fallopian Tube Endometrioid Adenocarcinoma", "Fallopian Tube Mucinous Adenocarcinoma", "Fallopian Tube Serous Adenocarcinoma", "Fallopian Tube Transitional Cell Carcinoma", "Fallopian Tube Undifferentiated Carcinoma", "Malignant Ovarian Brenner Tumor", "Ovarian Clear Cell Adenocarcinoma", "Ovarian Endometrioid Adenocarcinoma", "Ovarian Mucinous Adenocarcinoma", "Ovarian Seromucinous Carcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Transitional Cell Carcinoma", "Ovarian Undifferentiated Carcinoma", "Primary Peritoneal Serous Adenocarcinoma", "Recurrent Fallopian Tube Carcinoma", "Recurrent Ovarian Carcinoma", "Recurrent Primary Peritoneal Carcinoma" ], "interventions": [ { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Mesenchymal Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter", "type": "BIOLOGICAL" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Chest Radiography", "type": "PROCEDURE" }, { "name": "Single Photon Tomography and Computed Tomography Scan", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2014-04-25", "completion_date": "2027-03-15", "has_results": true, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02068794" }, { "nct_id": "NCT04905836", "title": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "COVI-MSC", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Sorrento Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2021-11-16", "completion_date": "2023-03", "has_results": false, "last_update_posted_date": "2022-04-11", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 6, "location_summary": "Brandon, Florida • Sarasota, Florida • Boise, Idaho + 2 more", "locations": [ { "city": "Brandon", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Boise", "state": "Idaho" }, { "city": "Boise", "state": "Idaho" }, { "city": "Tulsa", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT04905836" }, { "nct_id": "NCT03840343", "title": "Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetic Kidney Disease", "Diabetic Nephropathies", "Diabetes Mellitus, Type 2", "Diabetes Mellitus, Type 1", "Chronic Kidney Disease", "Diabetic Nephropathy Type 2", "Kidney Failure", "Kidney Insufficiency" ], "interventions": [ { "name": "Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose", "type": "BIOLOGICAL" }, { "name": "Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 2, "start_date": "2019-10-23", "completion_date": "2020-08-04", "has_results": false, "last_update_posted_date": "2025-08-17", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03840343" }, { "nct_id": "NCT02674399", "title": "A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "JointStem", "type": "DRUG" }, { "name": "Synvisc-One", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nature Cell Co. Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "22 Years to 60 Years" }, "enrollment_count": 28, "start_date": "2016-02-16", "completion_date": "2018-12-28", "has_results": true, "last_update_posted_date": "2021-08-10", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 2, "location_summary": "Santa Monica, California • Walnut Creek, California", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02674399" }, { "nct_id": "NCT03171194", "title": "Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "System; Lupus Erythematosus" ], "interventions": [ { "name": "Low Dose Mesenchymal Stem Cells (MSCs)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 6, "start_date": "2017-04-27", "completion_date": "2018-10-25", "has_results": false, "last_update_posted_date": "2019-05-02", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Charleston, South Carolina", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03171194" }, { "nct_id": "NCT06775964", "title": "Stem Cell Therapy for Early Alzheimer's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cognitive Dysfunction" ], "interventions": [ { "name": "adMSC", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Paul E Schulz", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "60 Years to 80 Years" }, "enrollment_count": 12, "start_date": "2026-03-11", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-04-20", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06775964" }, { "nct_id": "NCT07546942", "title": "Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined.", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Autism Spectrum Disorder", "Autism", "Autism Spectral Disorder" ], "interventions": [ { "name": "Autologous MSC isolation, concentration, and cryopreservation of adult mesenchymal stem cells", "type": "PROCEDURE" }, { "name": "Fecal Biomicrome Transplantation (FMT)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Ketogenic RESET Diet Protocol", "type": "DIETARY_SUPPLEMENT" }, { "name": "Trial combines use of cSVF and MSCs (cryopres) with diet modification and FMT (fecal material Transplant in adult ASD patients", "type": "BEHAVIORAL" }, { "name": "FMT (Fecal Material Tranplantation)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Use autologous cSVF + MSCs (cryo) for management of autoimmune component, anti-inflammatory and immune modulation", "type": "BIOLOGICAL" } ], "intervention_types": [ "PROCEDURE", "DIETARY_SUPPLEMENT", "BEHAVIORAL", "BIOLOGICAL" ], "sponsor": "Black Tie Medical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "10 Years to 90 Years" }, "enrollment_count": 50, "start_date": "2026-04-30", "completion_date": "2030-08-14", "has_results": false, "last_update_posted_date": "2026-04-27", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 2, "location_summary": "Hamilton, Montana", "locations": [ { "city": "Hamilton", "state": "Montana" }, { "city": "Hamilton", "state": "Montana" } ], "official_url": "https://clinicaltrials.gov/study/NCT07546942" }, { "nct_id": "NCT07048314", "title": "Stem Cells for Erectile Dysfunction Post RALP", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Erectile Dysfunction", "Prostate Cancer" ], "interventions": [ { "name": "Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office", "type": "DRUG" }, { "name": "Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the OR", "type": "DRUG" }, { "name": "Placebo in the OR", "type": "DRUG" }, { "name": "Placebo in clinic", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Methodist Hospital Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "MALE", "summary": "40 Years to 70 Years · Male only" }, "enrollment_count": 40, "start_date": "2026-07-07", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07048314" }, { "nct_id": "NCT03117738", "title": "A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "AstroStem", "type": "DRUG" }, { "name": "Placebo-Control", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Nature Cell Co. Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 21, "start_date": "2017-05-09", "completion_date": "2019-08-31", "has_results": true, "last_update_posted_date": "2021-08-10", "last_synced_at": "2026-10-02T07:33:15.075Z", "location_count": 3, "location_summary": "Costa Mesa, California • Santa Ana, California • Honolulu, Hawaii", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT03117738" } ] }